Unlock stock picks and a broker-level newsfeed that powers Wall Street.
ASX - Delayed Quote AUD

PainChek Limited (PCK.AX)

Compare
0.0330
+0.0020
+(6.45%)
At close: April 4 at 4:10:37 PM GMT+11
Loading Chart for PCK.AX
  • Previous Close 0.0310
  • Open 0.0310
  • Bid 0.0310 x --
  • Ask 0.0330 x --
  • Day's Range 0.0310 - 0.0330
  • 52 Week Range 0.0240 - 0.0440
  • Volume 1,099,811
  • Avg. Volume 1,066,981
  • Market Cap (intraday) 60.783M
  • Beta (5Y Monthly) 0.44
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Feb 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, which uses cameras in smartphones and tablets for a facial scan that is analyzed in real time using facial recognition software to indicate the presence of pain. It serves patients suffering with dementia and pre-verbal infants; and the aged care, disability, home care, hospital, and infant sectors. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.

www.painchek.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: PCK.AX

View More

Performance Overview: PCK.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

PCK.AX
13.79%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

PCK.AX
6.45%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

PCK.AX
23.01%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

PCK.AX
60.11%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: PCK.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PCK.AX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    60.78M

  • Enterprise Value

    57.90M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    18.34

  • Price/Book (mrq)

    26.21

  • Enterprise Value/Revenue

    19.95

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -269.86%

  • Return on Assets (ttm)

    -114.82%

  • Return on Equity (ttm)

    -457.46%

  • Revenue (ttm)

    3.03M

  • Net Income Avi to Common (ttm)

    -8.17M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.88M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -4.72M

Research Analysis: PCK.AX

View More

Company Insights: PCK.AX

Research Reports: PCK.AX

View More

People Also Watch